BTAI BioXcel Therapeutics
BioXcel Therapeutics earnings company data as of 7:30 PM ET 8/20
- 1 of 1 EPS beats
History
1 period, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q2 | 13 Aug | EPS | -0.58 | -0.49 | Beat |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by BTAI's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- None no sales outside a trading plan
- None no planned (10b5-1) sales
No open-market buys or sales on file.
Also filed in the last 12 months, not counted as buying or selling: 29 option exercises and 4 sales to cover taxes.
SEC filings
Recent issuer filings from EDGAR, 23 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 2.03,3.01 | Filing Doc | |
| 8-K | 1.01,1.03 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 1.01,9.01 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 3.02,9.01 | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| 424B5 | Filing Doc | ||
| 8-K | 1.01,9.01 | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| 8-K | 8.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.